3.94
price up icon0.51%   0.02
after-market Handel nachbörslich: 4.00 0.06 +1.52%
loading

Prime Medicine Inc Aktie (PRME) Neueste Nachrichten

pulisher
02:46 AM

How Prime Medicine Inc. stock reacts to bond yieldsTrade Exit Report & Weekly Breakout Stock Alerts - ulpravda.ru

02:46 AM
pulisher
02:40 AM

Is Prime Medicine Inc. stock a safe buy before earningsJuly 2025 Outlook & Technical Entry and Exit Tips - ulpravda.ru

02:40 AM
pulisher
Jan 08, 2026

How Prime Medicine Inc. stock benefits from tech adoptionWeekly Market Summary & Weekly Return Optimization Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

What hedge fund activity signals for Prime Medicine Inc. stockIndex Update & AI Based Buy/Sell Signal Reports - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Dip Buying: How Prime Medicine Inc. stock benefits from tech adoptionJuly 2025 Chart Watch & High Yield Stock Recommendations - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Prime Medicine initiated with an outperform at LifeSci Capital - MSN

Jan 08, 2026
pulisher
Jan 08, 2026

Los Angeles Daily NewsPrime Medicine, Inc.Common Stock (Nasdaq:PRME) Stock Quote - FinancialContent

Jan 08, 2026
pulisher
Jan 07, 2026

Prime Medicine (NYSE:PRME) Trading 7.5% HigherWhat's Next? - MarketBeat

Jan 07, 2026
pulisher
Jan 07, 2026

How Prime Medicine Inc. stock reacts to oil pricesBullish Engulfing Patterns & High Profit Trading Alerts - ulpravda.ru

Jan 07, 2026
pulisher
Jan 07, 2026

Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 07, 2026
pulisher
Jan 03, 2026

Prime Medicine, Inc. (PRME) announces NEJM publication of PM359 data - MSN

Jan 03, 2026
pulisher
Jan 02, 2026

Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize - Benzinga

Jan 02, 2026
pulisher
Dec 31, 2025

Prime: Maintaining "Buy" On Solidified Catalysts For Wilson's Disease And Beyond - Seeking Alpha

Dec 31, 2025
pulisher
Dec 31, 2025

Prime Medicine (NYSE:PRME) Trading Down 3.3%Here's What Happened - MarketBeat

Dec 31, 2025
pulisher
Dec 31, 2025

LifeSci Capital Initiates Prime Medicine (PRME), Highlights One-and-Done Potential in Liver and Lung Diseases - Insider Monkey

Dec 31, 2025
pulisher
Dec 30, 2025

Prime Medicine, Inc. (PRME) Announces NEJM Publication Of PM359 Data - Insider Monkey

Dec 30, 2025
pulisher
Dec 29, 2025

10 Best Biotech Penny Stocks to Buy According to Analysts - Insider Monkey

Dec 29, 2025
pulisher
Dec 25, 2025

Lifesci Capital Predicts Prime Medicine FY2025 Earnings - MarketBeat

Dec 25, 2025
pulisher
Dec 24, 2025

Prime Medicine (NASDAQ:PRME) Trading Down 3.8%Here's What Happened - MarketBeat

Dec 24, 2025
pulisher
Dec 24, 2025

Prime Medicine (NYSE:PRME) Stock Price Down 4.2%Should You Sell? - MarketBeat

Dec 24, 2025
pulisher
Dec 24, 2025

Prime Medicine (NASDAQ:PRME) Upgraded at Lifesci Capital - MarketBeat

Dec 24, 2025
pulisher
Dec 23, 2025

LifeSci Capital Initiates Coverage of Prime Medicine (PRME) with Outperform Recommendation - Nasdaq

Dec 23, 2025
pulisher
Dec 23, 2025

Lifesci Capital Begins Coverage on Prime Medicine (NYSE:PRME) - MarketBeat

Dec 23, 2025
pulisher
Dec 23, 2025

LifeSci Capital Initiates Prime Medicine(PRME.US) With Buy Rating, Announces Target Price $6 - 富途牛牛

Dec 23, 2025
pulisher
Dec 23, 2025

Prime Medicine: Buy Rating on Prime Editing Platform Targeting High-Value Liver and Lung Genetic Diseases, Led by PM577 in Wilson’s Disease - TipRanks

Dec 23, 2025
pulisher
Dec 23, 2025

Prime Medicine initiated with an Outperform at LifeSci Capital - TipRanks

Dec 23, 2025
pulisher
Dec 23, 2025

LifeSci Initiates Prime Medicine at Outperform With $6 Price Target - marketscreener.com

Dec 23, 2025
pulisher
Dec 22, 2025

Prime Medicine Earnings Notes - Trefis

Dec 22, 2025
pulisher
Dec 21, 2025

Prime Medicine, Inc.(NasdaqGM: PRME) added to S&P Biotechnology Select Industry Index - marketscreener.com

Dec 21, 2025
pulisher
Dec 21, 2025

Prime Medicine announces NEJM publication of PM359 data - MSN

Dec 21, 2025
pulisher
Dec 21, 2025

Prime Medicine, Inc. (NYSE:PRME) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Dec 21, 2025
pulisher
Dec 20, 2025

Quarterly Recap: How Prime Medicine Inc. stock reacts to oil pricesWatch List & Safe Entry Trade Reports - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Risks Report: Why Prime Medicine Inc. stock remains resilient2025 Market Trends & Real-Time Buy Signal Notifications - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

What technical charts say about Prime Medicine Inc. stockEarnings Overview Report & AI Powered Market Entry Strategies - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Why Prime Medicine Inc. stock remains resilientTrade Exit Summary & Weekly High Return Stock Forecasts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Can Prime Medicine Inc. stock hit record highs againJuly 2025 News Drivers & Weekly High Conviction Ideas - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Can Prime Medicine Inc. stock withstand economic slowdownTrade Signal Summary & Weekly Top Gainers Alerts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Is Prime Medicine Inc. stock in correction or buying zone2025 Stock Rankings & Consistent Growth Equity Picks - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Profit Recap: How Prime Medicine Inc. stock reacts to oil pricesRate Hike & Accurate Intraday Trading Signals - Улправда

Dec 19, 2025
pulisher
Dec 09, 2025

Prime Medicine's Market Cap Up US$161m Following Year Of Insider Stock Buying - simplywall.st

Dec 09, 2025
pulisher
Dec 08, 2025

Prime Medicine’s Stock Fluctuations: How Genomic Advances Steer Performance - StocksToTrade

Dec 08, 2025
pulisher
Dec 08, 2025

Prime Medicine (NYSE:PRME) Shares Gap UpShould You Buy? - MarketBeat

Dec 08, 2025
pulisher
Dec 08, 2025

Prime Medicine (NASDAQ:PRME) Shares Gap UpStill a Buy? - MarketBeat

Dec 08, 2025
pulisher
Dec 07, 2025

Prime Medicine Announces The New England Journal of - GlobeNewswire

Dec 07, 2025
pulisher
Dec 07, 2025

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease - Sahm

Dec 07, 2025
pulisher
Dec 07, 2025

Prime Medicine (Nasdaq: PRME) reports first-in-human PM359 CGD data in NEJM study - Stock Titan

Dec 07, 2025
pulisher
Dec 06, 2025

Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates - sharewise.com

Dec 06, 2025
pulisher
Dec 05, 2025

Prime Medicine (NYSE:PRME) Stock Price Up 10.2%Still a Buy? - MarketBeat

Dec 05, 2025
$106.87
price up icon 0.90%
$34.26
price up icon 1.87%
$118.64
price up icon 10.48%
$99.85
price up icon 1.01%
biotechnology ONC
$337.89
price up icon 5.47%
$175.97
price up icon 3.35%
Kapitalisierung:     |  Volumen (24h):